NYSE:DHR - Danaher Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$99.71 -2.79 (-2.72 %)
(As of 12/14/2018 11:37 AM ET)
Previous Close$102.50
Today's Range$99.71 - $101.72
52-Week Range$91.84 - $110.86
Volume37,761 shs
Average Volume2.40 million shs
Market Capitalization$71.51 billion
P/E Ratio24.85
Dividend Yield0.63%
Beta1.06
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
Current SymbolNYSE:DHR
Previous Symbol
CUSIP23585110
Phone202-828-0850

Debt

Debt-to-Equity Ratio0.38
Current Ratio1.53
Quick Ratio1.08

Price-To-Earnings

Trailing P/E Ratio24.85
Forward P/E Ratio22.11
P/E Growth1.96

Sales & Book Value

Annual Sales$18.33 billion
Price / Sales3.81
Cash Flow$5.7338 per share
Price / Cash Flow17.39
Book Value$37.91 per share
Price / Book2.63

Profitability

EPS (Most Recent Fiscal Year)$4.03
Net Income$2.49 billion
Net Margins14.07%
Return on Equity11.59%
Return on Assets6.63%

Miscellaneous

Employees67,000
Outstanding Shares700,900,000
Market Cap$71.51 billion
OptionableOptionable

Danaher (NYSE:DHR) Frequently Asked Questions

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Monday, December 3rd. Stockholders of record on Friday, December 28th will be paid a dividend of $0.16 per share on Friday, January 25th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, December 27th. View Danaher's Dividend History.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) posted its quarterly earnings results on Thursday, October, 18th. The conglomerate reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. The conglomerate had revenue of $4.85 billion for the quarter, compared to analyst estimates of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.00 earnings per share. View Danaher's Earnings History.

When is Danaher's next earnings date?

Danaher is scheduled to release their next quarterly earnings announcement on Tuesday, January 29th 2019. View Earnings Estimates for Danaher.

What guidance has Danaher issued on next quarter's earnings?

Danaher issued an update on its FY19 earnings guidance on Thursday, December, 13th. The company provided EPS guidance of $4.75-4.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.83.

What price target have analysts set for DHR?

14 equities research analysts have issued twelve-month price targets for Danaher's stock. Their forecasts range from $99.97 to $126.00. On average, they expect Danaher's stock price to reach $111.6131 in the next twelve months. This suggests a possible upside of 11.9% from the stock's current price. View Analyst Price Targets for Danaher.

What is the consensus analysts' recommendation for Danaher?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.

Has Danaher been receiving favorable news coverage?

Media coverage about DHR stock has trended somewhat positive recently, according to InfoTrie. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Danaher earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned news headlines about the conglomerate a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the stock's share price in the near term.

Who are some of Danaher's key competitors?

Who are Danaher's key executives?

Danaher's management team includes the folowing people:
  • Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 57)
  • Mr. Daniel L. Comas, CFO & Exec. VP (Age 54)
  • Ms. Angela S. Lalor, Sr. VP of HR (Age 53)
  • Mr. William K. Daniel II, Exec. VP (Age 53)
  • Mr. Rainer M. Blair, Exec. VP (Age 54)

Who are Danaher's major shareholders?

Danaher's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc (6.38%), BlackRock Inc. (6.20%), FMR LLC (3.10%), Massachusetts Financial Services Co. MA (3.00%), Putnam Investments LLC (0.92%) and Flossbach Von Storch AG (0.82%). Company insiders that own Danaher stock include Angela S Lalor, Brian W Ellis, Brijender (Binny) Jass Jassal, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, MERIAN GLOBAL INVESTORS UK Ltd, Mitsubishi UFJ Trust & Banking Corp, Bessemer Group Inc., Massachusetts Financial Services Co. MA, CIBC World Markets Inc., AXA and HealthCor Management L.P.. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.

Which institutional investors are buying Danaher stock?

DHR stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, AQR Capital Management LLC, FMR LLC, Vanguard Group Inc, Bank of Montreal Can, Capital International Investors, JPMorgan Chase & Co. and BlackRock Inc.. Company insiders that have bought Danaher stock in the last two years include Donald J Ehrlich and Mitchell P Rales. View Insider Buying and Selling for Danaher.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $99.71.

How big of a company is Danaher?

Danaher has a market capitalization of $71.51 billion and generates $18.33 billion in revenue each year. The conglomerate earns $2.49 billion in net income (profit) each year or $4.03 on an earnings per share basis. Danaher employs 67,000 workers across the globe.

What is Danaher's official website?

The official website for Danaher is http://www.danaher.com.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]


MarketBeat Community Rating for Danaher (NYSE DHR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  826 (Vote Outperform)
Underperform Votes:  456 (Vote Underperform)
Total Votes:  1,282
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel